Strategic Proposal for Selective Awakening and Targeted Elimination of Latent Viruses Through Molecular Pathway Disruption

Latent viral infections, such as those caused by Herpes Simplex Virus (HSV), Human Immunodeficiency Virus (HIV), and Epstein-Barr Virus (EBV), remain a major obstacle to achieving complete viral eradication. These pathogens establish dormancy within host cells, effectively evading immune detection and undermining standard antiviral therapies. This research proposal outlines a three-phase strategy that integrates nanotechnology and molecular biology to selectively reactivate latent viruses and eliminate them through targeted capture and neutralization mechanisms. By employing biomimetic nanostructures and phase-specific activation triggers, this approach seeks to minimize off-target effects and collateral damage, offering a controlled and replicable platform for treating chronic viral infections.